Both U.S. and non-U.S. financial institutions should evaluate and consider bolstering their transaction screening and export controls compliance.

Startups that develop, use or commercialize AI systems or general-purpose AI models used in the EU must comply with the EU AI Act.

The health care industry has used AI for decades, but the rise of generative AI raises questions about how to regulate the technology.

The most significant 2024 updates to the ECCP concern identifying and managing risks around new and emerging technologies, chiefly AI.

The Commerce Department’s BIS has proposed a rule that would establish reporting requirements to track development of advanced AI models.

Proposed AI legislation in California may have big implications in health care.